Navigation Links
Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review

Lexington, Mass. (PRWEB) June 19, 2013

Imprivata®, a leading global provider of healthcare IT security solutions, today announced that Imprivata OneSign® leads the single sign-on (SSO) category in the KLAS® 2013 Mid-Term Performance Review: Software & Services report. CIOs and other healthcare executives iwere nterviewed by KLAS laud Imprivata on the superior performance of its products and the quality of its customer service and support, and they indicate that Imprivata is integral to their long-term healthcare IT strategy.

“Imprivata is a strategic partner. The SSO product used in conjunction with smooth roaming creates an environment that is both efficient and highly valued by our users. Imprivata enables No Click Access™ to clinical systems and patient information that delivers both security and convenience that clinicians need to better focus on patient care,” said Bruce Hall, CIO of Augusta Health, a 255-bed hospital in Fisherville, Va. “In addition, Imprivata understands the evolving healthcare IT landscape. We expect Imprivata will remain central to our healthcare IT strategy over the long term.”

The KLAS 2013 Mid-Term Performance Review: Software & Services report profiles hundreds of software and services vendors, providing a detailed look at the performance of each company's product line. The report aggregates performance data gathered over the past 12 months. The findings represent the voice of thousands of providers sharing their candid experience with various healthcare technology and vendors. Imprivata OneSign received a score of 88.4, building on the company’s momentum from 2012 when it was recognized as the SSO category leader in the KLAS 2012 Top 20 Best in KLAS Awards report.

“KLAS rankings are derived directly from customer input, so our consistently high scores serve as strong independent validation of Imprivata’s products, customer service and strategic importance,” said Ed Gaudet, chief marketing officer of Imprivata. “Imprivata also has the highest U.S. market share among SSO providers, according to HIMSS Analytics data, which supports feedback that we regularly receive from customers—Imprivata is the most widely-used application in hospitals after the electronic medical records system. Imprivata is simplifying healthcare IT to enable our customers with better focus on patient care.”

About Imprivata
Imprivata, the leader in healthcare IT security, enables secure access and collaboration for two million healthcare users worldwide. As the #1 independent provider of single sign-on and access management solutions for healthcare and other regulated industries, Imprivata OneSign® Single Sign-On is exclusively endorsed by the American Hospital Association (AHA) and recognized by Gartner and KLAS. Imprivata Cortext™ is the leading free HIPAA compliant text messaging solution for healthcare. Headquartered in Lexington, Massachusetts, Imprivata serves 1,300 hospitals in partnership with over 200 EMR and technology infrastructure vendors around the world. For more information, please visit

All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. MEDITECH Customers According to HIMSS Analytics
2. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
3. Upstart Bachelorista Inc. Releases Tell-All Playbook For Single Women
4. Johns Hopkins surgeons among the first in the country to perform a robotic single-site hysterectomy
5. Talk Therapy Can Ease Depression, But No Single Type Deemed Best
6. LAPD Singles Out Narconon Drug Prevention and Education for Special Commendation
7. Northern Westchester Hospital Surgeon Reaches New Single-Incision Robot-Assisted Gallbladder Removal Surgery Milestone
8. Unique group for single fathers due to cancer offers support
9. Single Leg Deadlift Exercise Video Revealed By Bodyweight Torch
10. Single Concussion May Lead to Lasting Brain Damage
11. Single concussion may cause lasting brain damage
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap ... and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s ... STEMI and Sepsis conditions present in similar ways and require time-critical intervention to avoid ...
(Date:11/26/2015)... ON and Cambridge, ON (PRWEB) , ... November ... ... today the availability of a real-time eReferral system for diagnostic imaging in the ... ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic medical ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare ... participated in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was ... November 8th through Wednesday, November 11th, 2015. The conference was held at the ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Water For Empowerment ™ attracts volunteers together who want to combine talents ... women as key stakeholders in the process. The non-profit launched its first major ...
(Date:11/25/2015)... ... 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever clinic ... the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the Capillus272 ... need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... report to their offering. --> Research ... addition of the "Self Administration of High ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: